( NASDAQ-NMS:ICPT )

News from Intercept Pharmaceuticals A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 14, 2013, 06:05 ET Intercept Pharmaceuticals Reports Third Quarter 2013 Financial Results

 Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and...


Oct 08, 2013, 21:02 ET Intercept Announces Pricing of Public Offering of Common Stock By Selling Stockholders

 Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT), a clinical stage biopharmaceutical company focused on the development and...


Oct 01, 2013, 16:05 ET Additional Results of Global Primary Biliary Cirrhosis Study Group Analysis to be Presented at AASLD Annual Meeting

Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT)(Intercept), a clinical stage biopharmaceutical company focused on the development and...


Aug 13, 2013, 06:00 ET Intercept Pharmaceuticals Reports Second Quarter 2013 Financial Results

Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and...


Aug 05, 2013, 06:00 ET Intercept Pharmaceuticals to Present at the Wedbush Securities Life Sciences Management Access Conference

Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and...


Jul 01, 2013, 07:05 ET Intercept Pharmaceuticals to Present at the JMP Securities Healthcare Conference

 Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and...


Jun 24, 2013, 13:30 ET Intercept Pharmaceuticals Announces Completion of Public Offering and Exercise of Option to Purchase Additional Shares

 Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT), a clinical stage biopharmaceutical company focused on the development and...


Jun 18, 2013, 20:25 ET Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock

 Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT), a clinical stage biopharmaceutical company focused on the development and...


Jun 17, 2013, 06:00 ET Intercept Pharmaceuticals Announces Proposed Public Offering of Common Stock

 Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), a clinical stage biopharmaceutical company focused on the development and...


Aug 07, 2008, 01:00 ET Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling

NEW YORK, Aug. 7 /PRNewswire/ -- Historically, bile acids have been recognized primarily as natural detergents that regulate the absorption of...


Aug 12, 2004, 01:00 ET Intercept Pharmaceuticals Announces Publication of Study Demonstrating Its Lead Compound Can Reverse Liver Fibrosis

NEW YORK, Aug. 12 /PRNewswire/ -- Intercept Pharmaceuticals, Inc., an emerging specialty pharmaceutical company focused on developing small...